Drug makers typically raise their prices in the beginning of the year and 2022 has been no exception. A new study found that about 150 drug makers raised prices on 866 products in the U.S. during the first three weeks of the year by 6.6%. That’s slightly less than the overall inflation rate of 7% over the past year, but there still may be more drug price hikes on the way. Therefore, it’s possible that this could be a record year for drug price increase. Some of the numbers have been eye popping, such as the 536% increase Exelan Pharmaceuticals implemented for its generic high blood pressure treatment Lisinopril.